Hangzhou Tigermed Consulting (03347) spent 133 million yuan to repurchase 3.4114 million A-shares on June 16.
Tiger Pharmaceuticals (03347) announced that the company repurchased 3.4114 million A shares for 133 million RMB on June 16, 2026, at a repurchase price of 38.66-39.78 RMB per share.
Hangzhou Tigermed Consulting (03347) announced that on June 16, 2026, the company spent 133 million RMB to repurchase 3.4114 million A shares at a repurchase price of 38.66-39.78 RMB per share.
Related Articles
COMBA (02342) spent 226,700 Hong Kong dollars to repurchase 200,000 shares on June 16th.
CAOCAO INC (02643): Yuan Peng appointed as Vice President and Chief Financial Officer.
THELLOY DEV (01546) issued a profit warning, expecting the net loss for the year to decrease year-on-year to no more than HK$35 million.
COMBA (02342) spent 226,700 Hong Kong dollars to repurchase 200,000 shares on June 16th.
CAOCAO INC (02643): Yuan Peng appointed as Vice President and Chief Financial Officer.
THELLOY DEV (01546) issued a profit warning, expecting the net loss for the year to decrease year-on-year to no more than HK$35 million.
RECOMMEND
